Table 3.
Haemodynamic status and cardiovascular risk scores.
| Mean (SD) unless otherwise indicated | COPD (n = 185) | Control (n = 106) | p Value |
|---|---|---|---|
| Skin AGE (AU) | 3.1 (0.5) | 2.8 (0.6) | <0.001 |
| Aortic PWV (m/s) | 10.2 (2.3) | 9.6 (2.0) | 0.02 |
| Peripheral systolic BP (mmHg) | 146 (22) | 146 (17) | 0.95 |
| Peripheral diastolic BP (mmHg) | 84 (11) | 85 (11) | 0.74 |
| Peripheral PP (mmHg) | 62 (17) | 61 (14) | 0.90 |
| Peripheral MAP (mmHg) | 105 (13) | 105 (12) | 0.82 |
| HR (bpm) | 75 (15) | 71 (12) | 0.01 |
| Central PP (mmHg) | 58 (17) | 58 (13) | 1.0 |
| Central MAP (mmHg) | 110 (14) | 111 (12) | 0.67 |
| Total cholesterol (mmol/L) | 5.1 (1.2) | 5.3 (1.2) | 0.13 |
| LDL cholesterol (mmol/L) | 2.7 (1.0) | 2.9 (1.0) | 0.16 |
| HDL cholesterol (mmol/L) | 1.7 (0.5) | 1.6 (0.4) | 0.32 |
| sRAGE (pg/mL)a | 949.9 (1.7) | 1057.1 (1.6) | 0.09 |
| eGFR (mL/min) | 70 (14) | 73 (12) | 0.24 |
| ACC/AHA CV risk score (COPD n = 152, controls n = 98) | 20.2 (13.5) | 17.4 (12.7) | 0.09 |
| NHLBI CV risk score (COPD n = 132, controls n = 88) | 10.9 (7.8) | 10.3 (7.9) | 0.54 |
PP: pulse pressure; ACC/AHA: American College of Cardiology/American Heart Association; BP: blood pressure; eGFR: estimated glomerular filtration rate; MAP: mean arterial pressure; NHLBI: National Heart, Lung and Blood Institute; PWV: pulse wave velocity; sRAGE: soluble receptor for AGE; AGE: advanced glycation end products; COPD: chronic obstructive pulmonary disease; HR: heart rate.
aGeometric mean.